Kohlberg Acquires Majority Stake in Worldwide Clinical Trials
August 7, 2023
An affiliate of Kohlberg & Company agreed to acquire a majority stake in Worldwide Clinical Trials, a global contract research organization (CRO) headquartered in Research Triangle Park, North Carolina. The transaction is a recapitalization in which prior investor TJC, L.P. retains a meaningful minority equity stake; terms were not disclosed. Kohlberg will partner with Worldwide's management (Matt Jennings to become chairman) to support continued growth of the company's clinical trial and bioanalytical capabilities.
- Buyers
- Kohlberg & Company, LLC
- Targets
- Worldwide Clinical Trials
- Sellers
- TJC, L.P.
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Worldwide Clinical Trials Acquires Catalyst Clinical Research
February 17, 2026
Healthcare Services
Worldwide Clinical Trials completed its acquisition of oncology CRO Catalyst Clinical Research, expanding Worldwide’s oncology capabilities, biometrics, and functional service provider (FSP) offerings. The combined organization will operate with a workforce of approximately 4,400 employees across more than 70 countries, and financial terms were not disclosed.
-
Kohlberg & Company Recapitalizes Trinity Life Sciences
November 30, 2021
Healthcare Services
Kohlberg & Company will recapitalize Trinity Life Sciences, replacing Parthenon Capital as the company’s capital partner. The transaction provides Trinity with new growth capital to support global expansion, technology and data-driven capability investments while Trinity’s management team, led by CEO David Fitzhenry, will remain in place.
-
Altasciences Acquires WCCT Global
February 12, 2021
Healthcare Services
Altasciences acquired WCCT Global, an early‑stage clinical research organization (CRO) based in Southern California, expanding its West Coast clinical pharmacology capabilities and adding 180 clinical beds. The transaction, completed February 12, 2021, augments Altasciences’ Phase I/II services and expertise in specialized areas such as ethnobridging to support biopharmaceutical sponsors.
-
GI Partners Acquires Majority Stake in Clinical Ink
August 4, 2020
Cloud & SaaS
GI Partners will acquire a majority interest in Clinical Ink, a global clinical trial technology company headquartered in Horsham, Pennsylvania. The private investment firm will partner with Clinical Ink's management to accelerate product innovation, expand capabilities internationally, and pursue growth; existing investor NovaQuest will remain a minority shareholder. The transaction was expected to close in Q3 2020, subject to customary closing conditions.
-
Veristat Acquires The Clinical Trial Company Ltd (TCTC Group)
January 6, 2020
Healthcare Services
Veristat, a full-service CRO based in Southborough, Massachusetts, has acquired The Clinical Trial Company Ltd (TCTC Group), a Europe-headquartered contract research organization. The deal expands Veristat's European footprint and adds TCTC's expertise in gene and cell therapy, CNS and orphan disease clinical trials to Veristat's service offering.
-
DFW Capital Partners Makes Strategic Investment in WorldCare Clinical
January 6, 2020
Healthcare Services
DFW Capital Partners completed a significant investment in WorldCare Clinical, a global imaging contract research organization (CRO). The deal will support WorldCare's growth and capability expansion while CEO Aaron Timm remains in place and two DFW operating partners join WorldCare's board.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.